Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B

Innate Immunity

Volumn 21, Issue 6, 2015, Pages 665-673

  Yang, Zhiqing ^a   Tang, Tengqian ^a   Wei, Xiaolin ^a   Yang, Shuang ^b   Tian, Zhiqiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Internal Medicine Peoplea's Hospital of Zunyi County   (China)

Author keywords

chronic hepatitis B; GATA3; Innate lymphoid cells; T bet; telbivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 33; TELBIVUDINE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; VIRUS DNA; CYTOKINE; GATA3 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HELPER CELL; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MALE; PATHOGENESIS; TYPE 1 INNATE LYMPHOID CELL; TYPE 2 INNATE LYMPHOID CELL; ADAPTIVE IMMUNITY; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B; HEPATITIS B, CHRONIC; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; VIROLOGY;

HEPATITIS B VIRUS;

ADAPTIVE IMMUNITY; ADULT; CYTOKINES; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 84936135681     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425915586074     Document Type: Article

References (34)

1. Bertoletti A, Naoumov NV,. Translation of immunological knowledge into better treatments of chronic hepatitis B. J hepatol 2003; 39: 115-124.
2. Yang PL, Althage A, Chung J,. Immune effectors required for hepatitis B virus clearance. Proc Natl Sci U S A 2010; 107: 798-802.
3. Boni C, Penna A, Ogg GS,. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963-971.
4. Bertoletti A, Ferrari C,. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012; 61: 1754-1764.
5. Diefenbach A, Colonna M, Koyasu S,. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014; 41: 354-365.
6. McKenzie AN, Spits H, Eberl G,. Innate lymphoid cells in inflammation and immunity. Immunity 2014; 41: 366-374.
7. Spits H, Artis D, Colonna M,. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-149.
8. Sonnenberg GF, Fouser LA, Artis D,. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12: 383-390.
9. Spits H, Cupedo T,. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Ann Rev Immunol 2012; 30: 647-675.
10. Sonnenberg GF, Monticelli LA, Alenghat T,. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012; 336: 1321-1325.
11. Buonocore S, Ahern PP, Uhlig HH,. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464: 1371-1375.
12. Halim TY, Krauss RH, Sun AC,. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36: 451-463.
13. Chang YJ, Kim HY, Albacker LA,. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12: 631-638.
14. Kim BS, Siracusa MC, Saenz SA,. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013; 5: 170ra16-170ra16.
15. Roediger B, Kyle R, Yip KH, S,. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 2013; 14: 564-573.
16. Matsumoto A, Kanai T, Mikami Y,. IL-22-producing RORgammat-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis. PLoS One 2013; 8: e62853-e62853.
17. McHedlidze T, Waldner M, Zopf S,. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013; 39: 357-371.
18. Walker JA, Barlow JL, McKenzie AN,. Innate lymphoid cells-how did we miss them? Nat Rev Immunol 2013; 13: 75-87.
19. Li X, Liu X, Tian L, et al. Cytokine-mediated immunopathogenesis of hepatitis B virus infections. Clin Rev Allergy Immunol 2014 Dec 6 (Epub ahead of print).
20. Dienstag J, Easley C, Kirkpatrick P,. Telbivudine. Nat Rev Drug Discov 2007; 6: 267-268.
21. Chen Y, Li X, Ye B,. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res 2011; 91: 23-31.
22. Zheng Y, Huang Z, Chen X,. Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients. Mediators Inflamm 2012; 2012: 789859-789859.
23. Seki E, Schwabe RF,. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 2015; 61: 1066-1079.
24. Tian Z, Chen Y, Gao B,. Natural killer cells in liver disease. Hepatology 2013; 57: 1654-1662.
25. Sun C, Sun H, Zhang C, et al. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma. Cell Mol Immunol 2014 Oct 13 (Epub ahead of print).
26. Dunn C, Brunetto M, Reynolds G,. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204: 667-680.
27. Zhang Z, Zhang S, Zou Z,. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011; 53: 73-85.
28. Maloy KJ, Uhlig HH,. ILC1 populations join the border patrol. Immunity 2013; 38: 630-632.
29. Volarevic V, Mitrovic M, Milovanovic M,. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 2012; 56: 26-33.
30. Arshad MI, Piquet-Pellorce C, L'Helgoualc'h A,. TRAIL but not FasL and TNFalpha, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology 2012; 56: 2353-2362.
31. Sakai N, Van Sweringen HL, Quillin RC,. Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology 2012; 56: 1468-1478.
32. Li S, Zhu FX, Zhang HB,. Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice. Chin Med J (Engl) 2013; 126: 1855-1859.
33. Hammerich L, Tacke F,. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol 2014; 7: 297-306.
34. Liang Y, Jie Z, Hou L,. IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J Immunol 2013; 190: 5666-5675.